CPSC recall 22060
Over-the-counter drugs
- CPSC
- unknown
- Published 2022-01-26
On 2022-01-26 the CPSC announced a recall of Over-the-counter drugs by Geri Care Pharmaceuticals, citing the over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging….
| Agency | CPSC |
|---|---|
| Recall number | 22060 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2022-01-26 |
| Published | 2022-01-26 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Geri Care Pharmaceuticals |
| Distribution | US |
Product
Over-the-counter drugs | This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000
Reason
The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.